Position in DHR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$523,629
-$107,359 QoQ
Shares Held
2,749
-17.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,339
of 2,098 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $3,302,947 across 6 Diagnostics & Research names. DHR ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,495 | $1,752,253 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
2,749 | $523,629 | |
| 3 | A |
Agilent Technologies, Inc.
|
2,236 | $297,007 | |
| 4 | ILMN |
Illumina, Inc.
|
1,539 | $270,602 | |
| 5 | NTRA |
Natera, Inc.
|
881 | $239,147 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
416 | $220,309 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $523,629 | 2,749 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $630,988 | 3,328 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $722,471 | 3,156 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $531,931 | 2,683 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $391,326 | 1,981 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $352,190 | 1,718 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $354,884 | 1,546 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $434,545 | 1,563 | Shares | Sole | 2025-01-03 | |
| 2024-06-30 | $327,303 | 1,310 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $290,174 | 1,162 | Shares | Sole | 2024-05-29 | |
| 2022-12-31 | $2,516,712 | 9,482 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||